Camillo Porcaro is a professor of bioengineering at the Department of Neuroscience at the University of Padova. He is a computational neuroscientist with a core interest in developing analytical methods for extracting information from non-invasive measures of brain activity. His research, which has been published in numerous peer-reviewed scientific journals, focuses on identifying functional brain sources from data obtained through neuroimaging techniques. His work has significantly advanced our understanding of brain function and has practical applications in the diagnosis and treatment of neurological disorders. His journey in academia began in 2008 when he defended his doctoral thesis in 'Functional Neuroimaging: from Cells to Systems' with honours at the Institute of Advanced Biomedical Technologies (ITAB), University of Chieti, Italy. The same year, he embarked on a Postdoctoral Fellowship at the University of Birmingham—School of Psychology, where he pioneered the use of simultaneous EEG/fMRI. In 2011, he further solidified his expertise by joining the Institute of Neuroscience, Newcastle University, after securing a highly competitive independent research position. From October 2011 to September 2021, he was an Independent Researcher at the Institute of Cognitive Sciences and Technologies (ISTC) - National Research Council (CNR), Rome, Italy. Furthermore, in 2014 and 2015, he was invited as Visiting Professor at the Neural Control of Movement Lab, Department of Health Sciences and Technology ETH, Zurich, Switzerland and from 2015 to 2022 as an Adjunct Professor at the Department of Information Engineering – Polytechnic University of Marche, Ancona (Professor of Bio-imaging and Brain Research at the Department of Biomedical Engineering). In addition, from 2016 to 2020, he was Visiting Professor at the Department of Human Kinesiology, Movement Control & Neuroplasticity Research Group, KU Leuven, Belgium and from 2018 to 2021, he was Head of the Research hdEEG Lab at S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), Crotone, Italy. Finally, since October 2021, he has been appointed Associate Professor at Padua University - Department of Neuroscience. His dedication to advancing the field is evident in his extensive publication record, which includes over 100 articles in peer-reviewed scientific journals, many of which have high-impact factors. His work has been widely recognized, with a Google Scholar profile that boasts 3819 citations, an h-index of 38, and an i10-index of 79. He has also shared his insights as an invited speaker at prestigious research centers and international conferences, and his role as an associate editor for several journals and a reviewer for funding agencies further demonstrates his commitment to knowledge dissemination. He currently holds the following roles:  Associate Professor at the Department of Neuroscience (ING-INF/06).  Academic Board Member of the PhD in Neuroscience (PNC).  Associate researcher at the Institute of Cognitive Sciences and Technologies (ISTC) – National Research Council (CNR), Rome, Italy  IEEE Senior Member.  External expert assisting the European Research Executive Agency.  Honorary Senior Research Fellow - School of Psychology, Birmingham University Imaging Center (BUIC), Birmingham, UK.  Ordinary Member of the National Group of Biomedical Engineering. National scientific qualifications (ASN - Professor in the Italian higher education system):  Associate Professor in Bioengineering (09/G2 – ING-INF/06).  Full Professor in Physiology (BIO/09 - 05/D1).  Full Professor in General psychology, psychobiology and psychometrics (11/E1).  Full Professor in Technology and methodology in medicine, nursing and sport sciences (06/N1)

She recently transitioned to academia as a Professor of Process Engineering at Wilhelm Büchner Hochschule, after gaining over a decade of experience in industry R&D at global (bio)pharma companies. My mission is to impart knowledge and foster innovation, leveraging my extensive industry expertise and versatile academic background to inspire the next generation of engineers.

Founder of the Brain Institute of America and dedicated to eradicating brain cancer. Our company has over a decade of experience in the noncoding RNA field, and we are using this knowledge to develop biomarkers for neurologic disorders, glioblastoma, and rare forms of brain cancer. Since the formation of my company we have made collaborations across the country to foster the development of novel RNA biomarkers to detect these disorders. Our team is dedicated to finding cures for those with this disease.